David Moffat

Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions

James J. Going, David Moffat · The Journal of Pathology · 2004 · 176 citations

Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer

Wendy A. Cooper, Prudence A. Russell, Maya Cherian et al. · Clinical Cancer Research · 2017 · 134 citations

Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor

David Moffat, Sanjay R. Patel, Francesca A. Day et al. · Journal of Medicinal Chemistry · 2010 · 82 citations · Full text

Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs

Lindsey Needham, Alan H. Davidson, Lindsay J. Bawden et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 68 citations

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Emily Pulford, Kalyani Huilgol, David Moffat et al. · Disease Markers · 2017 · 54 citations · Full text

Early Diagnosis, Surgical Oncology, Tumoral Pathology +13